
- Applied Clinical Trials-10-01-2012
- Volume 21
- Issue 10
Site-Cost Line Item Charges on the Rise
Tufts CSDD
Clinical grants are growing increasingly sophisticated. Consquently, investigator site startup costs have become increasingly complex as well. Clinical sites are charging for a greater amount of site-cost line items. In addition, sites are charging more for those line items.
TTC's GrantPlan database contains grants from 76% of global clinical trials. GrantPlan tracks all the site-cost line items from clinical grants. The most common site costs are general site startup administrative fees, advertising, IRB fees, and pharmacy fees.
In 2010 the average number of line items included in global clinical grant site costs was 2.9 line items. That number increased to 3.0 in 2011, and is currently approaching 3.1 line items in 2012. Advertising fees are most responsible for the additional line items.
Additionally, sites are charging more for individual line items. The single most common site cost is the general administrative site startup fee. Between 2010 and 2011 the average site startup administrative fee increased 8%. Halfway through 2012, the average startup administrative fee has increased 3%.
—TTC (for more information, please contact
Articles in this issue
over 13 years ago
Applied Clinical Trials Digital Edition - October 2012over 13 years ago
Business and News Update October 2012over 13 years ago
Virtual Trials Come Under Growing Scrutinyover 13 years ago
EDC Autoquery Rate - A Marker for Site Qualityover 13 years ago
Warning Letter Studyover 13 years ago
Diagnostics Needed for Personalized Medicineover 13 years ago
Research, Practice, and Learningover 13 years ago
The Local Touchover 13 years ago
Managing Customer Expectationsover 13 years ago
Act CoverNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.




